drugset / Trial / NCT05249153
Dexmedetomidine and Sufentanil Effect in PCA on Pediatric Patients Undergoing Scoliosis Surgery
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary purpose of this three-arm single center, randomized, subject and assessor blind, controlled clinical study is to evaluate the effect of dexmedetomidine on patient-controlled intravenous analgesia after pediatric scoliosis orthopedics.
Timeline
- Start
- 2020-09-23
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.05 ug/kg | Intravenous |
| Subject | Dexmedetomidine | Other / unclassified | 0.1 ug/kg | Intravenous |
| Background | Sufentanil | Other / unclassified | 0.05 ug/kg | Intravenous |
Indications
No indication recorded.